Ackrell Capital, LLC
OrganizationRelationship Network
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
FINRA / SIPC
|
Membership |
7
|
3 | |
|
organization
FINRA
|
Membership |
6
|
2 | |
|
organization
SIPC
|
Membership |
6
|
2 | |
|
organization
Wana Brands
|
Investment analysis |
5
|
1 | |
|
person
FINRA/SIPC
|
Membership |
5
|
1 | |
|
organization
VCC Brands
|
Investment analysis |
5
|
1 | |
|
organization
Uber
|
Investment analysis |
5
|
1 | |
|
organization
Vapexhale
|
Investment analysis |
5
|
1 | |
|
organization
SC Labs
|
Business associate |
1
|
1 |
HOUSE_OVERSIGHT_024649.jpg
This document is page 13 of an Executive Summary from a 2017 Ackrell Capital investment report regarding the cannabis industry. It discusses the increase in strategic investor activity, citing investments by Constellation Brands and Scotts Miracle-Gro, while noting a continuing funding gap due to a lack of institutional support. The document outlines the investment outlook, noting that while billions were raised in 2017, most companies are in early development stages with revenues under $5 million. The document bears a 'HOUSE_OVERSIGHT_024649' stamp, suggesting it is part of a larger document production to the House Oversight Committee.
HOUSE_OVERSIGHT_024647.jpg
This document is page 11 of a 2017 Ackrell Capital executive summary report analyzing the cannabis industry. It discusses market dynamics, specifically the anticipated supply from South America, and details the significant banking challenges U.S. cannabis companies face due to federal laws and the Bank Secrecy Act (BSA), referencing FinCEN data on Suspicious Activity Reports (SARs). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was produced as part of a congressional investigation, though the text itself does not mention Jeffrey Epstein.
HOUSE_OVERSIGHT_024646.jpg
This page from an Ackrell Capital report discusses the potential first FDA approval of a cannabis-derived pharmaceutical (Epidiolex) in 2018 and its implications. It also analyzes the commoditization of cannabis flower, noting a downward pricing trend in legalized states like Colorado, Oregon, and Washington, illustrated by a graph of prices from 2016 to 2017.
HOUSE_OVERSIGHT_024645.jpg
This document appears to be page 9 of an executive summary for an investment report produced by Ackrell Capital, LLC in 2017. It focuses on the 'Mainstream Consumer Experience' within the cannabis industry, showcasing product photography for brands like Mountjoy Sparkling (cannabis-infused water) and Défoncé (chocolate), as well as images of high-end retail storefronts. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production for a congressional investigation, though no direct mention of Jeffrey Epstein appears on this specific page.
HOUSE_OVERSIGHT_024644.jpg
This document is page 8 of a December 2017 Cannabis Investment Report by Ackrell Capital, LLC. It analyzes the growth of the legal cannabis markets in California and Canada, predicting significant expansion in 2018 due to legislative changes like the Cannabis Act. The report also discusses the evolution of consumer products towards 'mainstream' acceptance, highlighting innovations in product types (concentrates, infused products) and the increasing sophistication of dispensaries and branding.
HOUSE_OVERSIGHT_024641.jpg
This document is page 5 of an executive summary from a 2017 report by Ackrell Capital, LLC regarding the cannabis industry. It features a text summary and a circular infographic detailing federal laws and policies impacting the industry, categorized into Drug and Food Regulation, Banking and Finance, and Intellectual Property. The document bears a 'HOUSE_OVERSIGHT_024641' Bates stamp, indicating it was part of a document production to the House Oversight Committee.
HOUSE_OVERSIGHT_024640.jpg
This document is page 4 of a Cannabis Investment Report by Ackrell Capital dated December 2017. It analyzes the U.S. state-legal cannabis market, estimating a total value of $8.0 billion with specific breakdowns for California, Colorado, Washington, and Oregon. The text discusses the legal conflict between state legalization and federal prohibition, noting the lack of bankruptcy protections and banking access, while highlighting DOJ and Treasury policies that have allowed the industry to operate. The document contains the Bates stamp HOUSE_OVERSIGHT_024640, indicating it is part of a House Oversight Committee production.
HOUSE_OVERSIGHT_024637.jpg
This document is an executive summary from a 2017 Ackrell Capital investment report regarding the global cannabis market. It analyzes market size, consumer statistics from the UNODC and RAND Corporation, and projects future growth based on anticipated federal legalization in the United States. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was likely obtained as part of a congressional investigation, though no specific individuals (Epstein or otherwise) are mentioned on this specific page.
HOUSE_OVERSIGHT_024635.jpg
This document is the foreword to the Ackrell Capital 2018 Cannabis Investment Report, dated December 28, 2017. It outlines the growth of the cannabis industry, recent legalization efforts in the US, Canada, and Germany, and market predictions. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production to the House Oversight Committee, the text itself contains no direct mention of Jeffrey Epstein, Ghislaine Maxwell, or specific transactions related to them.
HOUSE_OVERSIGHT_024632.jpg
This document is a page from an investment report produced by Ackrell Capital, LLC, dated roughly January 2018 (copyright 2017). It features two maps analyzing the legal status of cannabis globally and within the United States, distinguishing between recreational, medical, and limited access laws. The document bears a 'HOUSE_OVERSIGHT_024632' Bates stamp, indicating it was part of a document production for a US House Oversight Committee investigation, likely related to financial records or due diligence files, though Jeffrey Epstein is not explicitly named on this specific page.
HOUSE_OVERSIGHT_024631.jpg
This document is the cover and executive summary page of the '2018 Cannabis Investment Report' produced by Ackrell Capital, an investment bank based in San Francisco. It details global cannabis consumption statistics, the legal landscape in the U.S. and globally, and financial market estimates (predicting the legal market could exceed $100 billion). The document bears the Bates stamp 'HOUSE_OVERSIGHT_024631', indicating it was part of a document production for a House Oversight Committee investigation.
HOUSE_OVERSIGHT_024816.jpg
This document is the cover page for a 2017 report produced by Ackrell Capital, LLC, an investment firm based in San Francisco. The cover features a graphic of a globe made of cannabis leaves, implying the report focuses on the cannabis industry. It contains standard legal disclaimers regarding investment advice and conflicts of interest, along with a House Oversight Committee Bates stamp.
HOUSE_OVERSIGHT_024814.jpg
A 2018 market landscape chart titled 'The Green Field 2018' produced by Ackrell Capital. The document categorizes hundreds of cannabis industry companies into sectors such as Consumer Products (Flower, Infused), Vaporizers, Pharmaceuticals, Business Solutions (Software, Services), and Digital Media. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional investigation or subpoena.
HOUSE_OVERSIGHT_024813.jpg
This document is a 2018 market landscape infographic titled 'The Green Field 2018' produced by Ackrell Capital. It categorizes dozens of companies within the cannabis industry into sectors including Cultivation, Production Equipment, Testing Services, Dispensaries, E-Commerce, and Distribution Services. The document bears a Bates stamp 'HOUSE_OVERSIGHT_024813', indicating it is part of a document production for the House Oversight Committee, likely related to broader investigations involving financial networks or specific individuals (contextually linked to Epstein investigations via the prompt, though Epstein is not named in this specific image).
HOUSE_OVERSIGHT_024810.jpg
This document is page 174 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital, LLC. It serves as a glossary defining various terms and acronyms related to cannabis and international drug policy (e.g., UN, USDA, Vaporizer, Wax). The document bears the Bates stamp HOUSE_OVERSIGHT_024810, indicating it was part of a document production for the House Oversight Committee.
HOUSE_OVERSIGHT_024807.jpg
This document is page 171 from a 2017 report by Ackrell Capital, LLC. It contains a 'Glossary of Terms' specifically related to the cannabis industry (defining terms like THCA, Edible, Flower, Ganja) and relevant regulatory bodies (DEA, FDA, FinCEN). While the document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was produced as part of a Congressional investigation (potentially swept up in a broader request for financial documents), the content itself contains no direct references to Jeffrey Epstein, his associates, or his specific activities.
HOUSE_OVERSIGHT_024805.jpg
This document is page 169 (Chapter X) of a report produced by Ackrell Capital, LLC, dated 2017. It serves as a 'Glossary of Terms' specifically related to the cannabis industry, defining terms such as ACMPR, Aeroponics, BHO, Bong, BSA (Bank Secrecy Act), and various cannabinoids (CBC, CBD, CBDA, CBG, CBGA). The document bears the Bates stamp 'HOUSE_OVERSIGHT_024805', indicating it was part of a document production to the House Oversight Committee.
HOUSE_OVERSIGHT_024802.jpg
This document is page 166 of a Cannabis Investment Report produced by Ackrell Capital, LLC in December 2017. It details the legal and financial risks associated with the cannabis industry, specifically focusing on conflicts between federal and state laws regarding taxation, banking access, trademark registration, and bankruptcy protection. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024802,' indicating it was included in a document production to the House Oversight Committee.
HOUSE_OVERSIGHT_024801.jpg
This document is page 165 of a report by Ackrell Capital, LLC, dated 2017, detailing 'Chapter IX: Cannabis Industry Risk Factors.' It outlines the legal and financial risks associated with the cannabis industry in relation to U.S. Federal Law, specifically the Controlled Substances Act (CSA), warning of potential asset seizure, imprisonment, and regulatory hurdles regarding interstate commerce. The document bears a 'HOUSE_OVERSIGHT' bates stamp, indicating it is part of a larger document production to the House Oversight Committee.
HOUSE_OVERSIGHT_024798.jpg
This document is page 162 of a 'Cannabis Investment Report' dated December 2017, published by Ackrell Capital, LLC. It profiles four cannabis-related companies (Vapexhale, VCC Brands, Vuber, and Wana Brands), detailing their locations, websites, and business activities (primarily vaporizers and infused products). The document bears the Bates stamp HOUSE_OVERSIGHT_024798, indicating it was part of a document production for the House Oversight Committee.
HOUSE_OVERSIGHT_024797.jpg
This document is page 161 of a 2018 report by Ackrell Capital titled 'Top 100 Private Cannabis Companies.' It profiles four specific companies: Trellis, Trulieve, Utopia Farms, and VapeWorld, providing their locations, websites, and brief business descriptions. The document bears the Bates stamp HOUSE_OVERSIGHT_024797, indicating it was part of a document production to the House Oversight Committee.
HOUSE_OVERSIGHT_024796.jpg
This document is page 160 of a Cannabis Investment Report dated December 2017, authored by Ackrell Capital. It profiles four companies: Strainz, Teewinot Life Sciences, Tikun Olam, and Treez, providing their locations, websites, and brief business descriptions. The document bears the Bates stamp HOUSE_OVERSIGHT_024796, indicating it was part of a document production for a House Oversight Committee investigation.
HOUSE_OVERSIGHT_024794.jpg
This document is page 158 of a Cannabis Investment Report dated December 2017, published by Ackrell Capital, LLC. It profiles four companies operating in the cannabis industry: Rubicon Organics, S2S Development, SC Laboratories, and Scrubbed, providing their locations, websites, and brief business descriptions. The document bears the Bates stamp HOUSE_OVERSIGHT_024794, indicating it is part of a House Oversight Committee production.
HOUSE_OVERSIGHT_024793.jpg
This document is page 157 of a report titled 'Top 100 Private Cannabis Companies 2018' produced by Ackrell Capital, LLC. It profiles four specific companies: PharmaCielo, PRØHBTD Media, Qind, and River Collective, providing their locations, websites, and brief business descriptions. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024793', indicating it was part of a document production to the House Oversight Committee, though the specific page content does not mention Jeffrey Epstein or his associates directly.
HOUSE_OVERSIGHT_024789.jpg
This document is page 153 of an Ackrell Capital report titled 'Chapter VIII Top 100 Private Cannabis Companies 2018'. It provides business profiles for four companies: Level Blends, LivWell Enlightened Health, Lunchbox Alchemy, and Mary's Medicinals. The page bears the Bates stamp 'HOUSE_OVERSIGHT_024789', indicating it is part of a document production for a House Oversight Committee investigation, though no direct connection to Jeffrey Epstein is explicitly mentioned in the text of this specific page.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity